Published in Clin Endocrinol (Oxf) on December 01, 1999
Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol (2011) 1.03
Safety and efficacy of testosterone gel in the treatment of male hypogonadism. Clin Interv Aging (2009) 0.87
Androgen supplementation and prostate cancer risk: strategies for pretherapy assessment and monitoring. Rev Urol (2003) 0.82
Testosterone depot injection in male hypogonadism: a critical appraisal. Clin Interv Aging (2007) 0.82
Testosterone deficiency: a historical perspective. Asian J Androl (2014) 0.80
An update on male hypogonadism therapy. Expert Opin Pharmacother (2014) 0.80
Androgen Receptor Gene CAG Repeat Polymorphism Regulates the Metabolic Effects of Testosterone Replacement Therapy in Male Postsurgical Hypogonadotropic Hypogonadism. Int J Endocrinol (2013) 0.78
Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes. Int J Nanomedicine (2013) 0.77
Male contraception. Fertil Steril (2016) 0.75
Suppression of spermatogenesis by testosterone undecanoate-loaded injectable in situ-forming implants in adult male rats. Asian J Androl (2016) 0.75
New long-acting androgens. World J Urol (2003) 0.75
Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78
Lifespan and testosterone. Nature (1993) 2.84
Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male (2005) 2.60
Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med (1997) 2.52
Creatine kinase activity in human spermatozoa and seminal plasma lacks predictive value for male fertility in in vitro fertilization. Fertil Steril (1998) 1.98
The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. Climacteric (2000) 1.91
External quality control in the andrology laboratory: an experimental multicenter trial. Fertil Steril (1990) 1.65
The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36. Climacteric (2000) 1.62
Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab (2000) 1.60
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol (2008) 1.55
Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol (1996) 1.53
Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology (2004) 1.46
Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril (1995) 1.45
[The Kallmann syndrome. Its pathophysiology and clinical picture]. Dtsch Med Wochenschr (1994) 1.39
Testosterone replacement therapy: current trends and future directions. Hum Reprod Update (2004) 1.33
Indoor air pollution and airway disease. Int J Tuberc Lung Dis (2004) 1.31
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl (2008) 1.31
Loss of the deltoid after shoulder operations: An operative disaster. J Shoulder Elbow Surg (2009) 1.29
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl (2006) 1.26
Partial deletions in the AZFc region of the Y chromosome occur in men with impaired as well as normal spermatogenesis. Hum Reprod (2004) 1.24
Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol (2001) 1.24
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res (2008) 1.22
Phenotypic variation within European carriers of the Y-chromosomal gr/gr deletion is independent of Y-chromosomal background. J Med Genet (2008) 1.10
A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab (2005) 1.09
Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Hum Reprod Update (2008) 1.07
Clinical experience with azoospermia: aetiology and chances for spermatozoa detection upon biopsy. Int J Androl (2010) 1.06
Serum FSH and testicular morphology in male infertility. Clin Endocrinol (Oxf) (1994) 1.05
EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: state-of-the-art 2013. Andrology (2014) 1.05
Screening for deletions of the Y chromosome involving the DAZ (Deleted in AZoospermia) gene in azoospermia and severe oligozoospermia. Fertil Steril (1997) 1.05
Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol (2005) 1.04
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl (2005) 1.03
Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab (2000) 1.03
An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab (1996) 1.03
Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab (1999) 1.02
Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol (Oxf) (1999) 1.02
Third-hand smoke exposure and health hazards in children. Monaldi Arch Chest Dis (2013) 1.02
Chromosome abnormalities in 447 couples undergoing intracytoplasmic sperm injection--prevalence, types, sex distribution and reproductive relevance. Hum Reprod (1998) 1.01
Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene (2006) 0.98
Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J (1998) 0.97
Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol (1998) 0.97
Y-chromosomal microdeletions and partial deletions of the Azoospermia Factor c (AZFc) region in normozoospermic, severe oligozoospermic and azoospermic men in Sri Lanka. Asian J Androl (2006) 0.97
Case report: natural transmission of an AZFc Y-chromosomal microdeletion from father to his sons. Hum Reprod (2004) 0.97
Update on treatment of varicocele: counselling as effective as occlusion of the vena spermatica. Hum Reprod (1998) 0.97
Adverse respiratory effects of outdoor air pollution in the elderly. Int J Tuberc Lung Dis (2012) 0.96
Long-term follow-up of toluene diisocyanate-induced asthma. Eur Respir J (2003) 0.96
Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol (1996) 0.95
The Po River Delta Respiratory Epidemiological Survey: an analysis of factors related to level of total serum IgE. Eur Respir J (1998) 0.95
Surgical ligation vs. angiographic embolization of the vena spermatica: a prospective randomized study for the treatment of varicocele-related infertility. Andrologia (1993) 0.94
Investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Androl (2008) 0.94
Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a). J Clin Endocrinol Metab (1997) 0.92
Prevalence of Y chromosome microdeletions in infertile men who consulted a tertiary care medical centre: the Münster experience. Andrologia (2001) 0.92
Role of FSH in the regulation of spermatogenesis: clinical aspects. Clin Endocrinol (Oxf) (1999) 0.91
Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. Eur J Endocrinol (1999) 0.91
Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J Clin Endocrinol Metab (2001) 0.90
Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignancies. Hum Reprod (1997) 0.90
Topotecan in the treatment of refractory neuroblastoma and other malignant tumors in childhood - a phase-II-study. Klin Padiatr (2002) 0.89
Correlations between hormones, physical, and affective parameters in aging urologic outpatients. Eur Urol (2005) 0.89
Chorionic gonadotrophin beta subunit mRNA but not luteinising hormone beta subunit mRNA is expressed in the pituitary of the common marmoset (Callithrix jacchus). J Mol Endocrinol (2004) 0.89
Inhibin B is a more sensitive marker of spermatogenetic damage than FSH in the irradiated non-human primate model. J Endocrinol (1999) 0.88
Reversion of the differentiated phenotype and maturation block in Sertoli cells in pathological human testis. Hum Reprod (1999) 0.88
A common haplotype of protamine 1 and 2 genes is associated with higher sperm counts. Int J Androl (2009) 0.88
Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders. J Clin Endocrinol Metab (1995) 0.87
Age-related changes in plasma dehydroepiandrosterone sulphate, cortisol, testosterone and free testosterone circadian rhythms in adult men. Horm Res (1988) 0.87
cynDAZLA: a cynomolgus monkey homologue of the human autosomal DAZ gene. Mol Hum Reprod (1997) 0.87
Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications. Oncogene (2006) 0.86
Mutation analysis of the X-chromosome linked, testis-specific TAF7L gene in spermatogenic failure. Andrologia (2007) 0.86
Polymorphism of the FSH receptor and ovarian response to FSH. Ann Endocrinol (Paris) (2007) 0.86
Skin prick test reactivity to common aeroallergens in relation to total IgE, respiratory symptoms, and smoking in a general population sample of northern Italy. Allergy (1996) 0.86
Strong association between serum levels of leptin and testosterone in men. Clin Endocrinol (Oxf) (1997) 0.86
Frequently subnormal semen profiles of normal volunteers recruited over 17 years. Int J Androl (1997) 0.86
CFTR gene mutations in men with bilateral ejaculatory-duct obstruction and anomalies of the seminal vesicles. Am J Hum Genet (1997) 0.86
Intratesticular testosterone is increased in men with Klinefelter syndrome and may not be released into the bloodstream owing to altered testicular vascularization– a preliminary report. Andrology (2014) 0.86
HTLV-I infection in western equatorial Africa. Lancet (1989) 0.85
Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, testicular size, and serum inhibin levels in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis). Endocrinology (1991) 0.85
Pharmacokinetics and pharmacodynamics of testosterone enanthate and dihydrotestosterone enanthate in non-human primates. Acta Endocrinol (Copenh) (1990) 0.85
Leydig cell tumor in an anabolic steroid abuser. J Endocrinol Invest (2013) 0.85
Distribution and function of FSH receptor genetic variants in normal men. Andrologia (2002) 0.85
Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad link. Leukemia (2006) 0.85
The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age. Hum Reprod (2013) 0.85
Reproductive parameters of older compared to younger men of infertile couples. Int J Androl (1996) 0.85
Low-level sex chromosome mosaicism in female partners of couples undergoing ICSI therapy does not significantly affect treatment outcome. Hum Reprod (2001) 0.84
Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception. J Clin Endocrinol Metab (1999) 0.84
Atherosclerosis in apolipoprotein E-deficient mice is decreased by the suppression of endogenous sex hormones. Horm Metab Res (2001) 0.84
Characteristics of nonsmoking women exposed to spouses who smoke: epidemiologic study on environment and health in women from four Italian areas. Environ Health Perspect (2000) 0.84
Androgen receptor gene CAG and GGN polymorphisms in infertile Nigerian men. J Endocrinol Invest (2009) 0.84
Lack of correlation between cadmium in seminal plasma and fertility status of nonexposed individuals and two cadmium-exposed patients. Reprod Toxicol (1996) 0.84
Colorectal cancer screening: results of a 5-year program in asymptomatic subjects at increased risk. Dig Liver Dis (2006) 0.84
Number of offspring and maternal allergy. Allergy (2005) 0.84
Natural transmission of a partial AZFb deletion of the Y chromosome over three generations: case report. Hum Reprod (2002) 0.83
High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. Eur J Endocrinol (1994) 0.83
Clustering of male infertility in the families of couples treated with intracytoplasmic sperm injection. Hum Reprod (2000) 0.83
A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty. J Clin Endocrinol Metab (1998) 0.83
Transmission of a Y chromosomal deletion involving the deleted in azoospermia (DAZ) and chromodomain (CDY1) genes from father to son through intracytoplasmic sperm injection: case report. Hum Reprod (1999) 0.83